PMID- 30612527 OWN - NLM STAT- MEDLINE DCOM- 20191219 LR - 20200309 IS - 1524-4571 (Electronic) IS - 0009-7330 (Print) IS - 0009-7330 (Linking) VI - 124 IP - 5 DP - 2019 Mar TI - Microglial Cells Impact Gut Microbiota and Gut Pathology in Angiotensin II-Induced Hypertension. PG - 727-736 LID - 10.1161/CIRCRESAHA.118.313882 [doi] AB - RATIONALE: Increased microglial activation and neuroinflammation within autonomic brain regions have been implicated in sustained hypertension, and their inhibition by minocycline-an anti-inflammatory antibiotic-produces beneficial effects. These observations led us to propose a dysfunctional brain-gut communication hypothesis for hypertension. However, it has been difficult to reconcile whether an anti-inflammatory or antimicrobial action is the primary beneficial effect of minocycline in hypertension. Accordingly, we utilized chemically modified tetracycline-3 (CMT-3)-a derivative of tetracycline that has potent anti-inflammatory activity-to address this question. OBJECTIVE: Test the hypothesis that central administration of CMT-3 would inhibit microglial activation, attenuate neuroinflammation, alter selective gut microbial communities, protect the gut wall from developing hypertension-associated pathology, and attenuate hypertension. METHODS AND RESULTS: Rats were implanted with radiotelemetry devices for recording mean arterial pressure. Ang II (angiotensin II) was infused subcutaneously using osmotic mini-pumps to induce hypertension. Another osmotic mini-pump was surgically implanted to infuse CMT-3 intracerebroventricularly. Intracerebroventricular CMT- 3 infusion was also investigated in SHR (spontaneously hypertensive rats). Physiological, pathological, immunohistological parameters, and fecal microbiota were analyzed. Intracerebroventricular CMT-3 significantly inhibited Ang II-induced increases in number of microglia, their activation, and proinflammatory cytokines in the paraventricular nucleus of hypothalamus. Further, intracerebroventricular CMT-3 attenuated increased mean arterial pressure, normalized sympathetic activity, and left ventricular hypertrophy in Ang II rats, as well as in the SHR. Finally, CMT-3 beneficially restored certain gut microbial communities altered by Ang II and attenuated pathological alterations in gut wall. CONCLUSIONS: These observations demonstrate that inhibition of microglial activation alone was sufficient to induce significant antihypertensive effects. This was associated with unique changes in gut microbial communities and profound attenuation of gut pathology. They suggest, for the first time, a link between microglia and certain microbial communities that may have implications for treatment of hypertension. FAU - Sharma, Ravindra K AU - Sharma RK AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Yang, Tao AU - Yang T AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Oliveira, Aline C AU - Oliveira AC AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Lobaton, Gilberto O AU - Lobaton GO AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Aquino, Victor AU - Aquino V AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Kim, Seungbum AU - Kim S AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Richards, Elaine M AU - Richards EM AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Pepine, Carl J AU - Pepine CJ AD - Department of Medicine (C.J.P.), College of Medicine, University of Florida, Gainesville. FAU - Sumners, Colin AU - Sumners C AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. FAU - Raizada, Mohan K AU - Raizada MK AD - From the Department of Physiology and Functional Genomics (R.K.S., T.Y., A.C.O., G.O.L., V.A., S.K., E.M.R., C.S., M.K.R.), College of Medicine, University of Florida, Gainesville. LA - eng GR - R01 HL033610/HL/NHLBI NIH HHS/United States GR - R01 HL102033/HL/NHLBI NIH HHS/United States GR - R01 HL132448/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Circ Res JT - Circulation research JID - 0047103 RN - 0 (Anti-Bacterial Agents) RN - 0 (Anti-Inflammatory Agents) RN - 0 (Antihypertensive Agents) RN - 0 (Tetracyclines) RN - 0 (tetracycline CMT-3) RN - 11128-99-7 (Angiotensin II) SB - IM CIN - Circ Res. 2019 Mar;124(5):671-673. PMID: 30817265 MH - Angiotensin II MH - Animals MH - Anti-Bacterial Agents/administration & dosage MH - Anti-Inflammatory Agents/administration & dosage MH - Antihypertensive Agents/*administration & dosage MH - Arterial Pressure/drug effects MH - Autonomic Nervous System/drug effects/physiopathology MH - Disease Models, Animal MH - Gastrointestinal Microbiome/*drug effects MH - Hypertension/*drug therapy/microbiology/pathology/physiopathology MH - Infusions, Intraventricular MH - Intestines/*drug effects/innervation/microbiology/pathology MH - Male MH - Microglia/*drug effects/pathology MH - Paraventricular Hypothalamic Nucleus/*drug effects/pathology/physiopathology MH - Rats, Inbred SHR MH - Rats, Inbred WKY MH - Tetracyclines/*administration & dosage PMC - PMC6395495 MID - NIHMS1518223 OTO - NOTNLM OT - CMT-3 OT - angiotensin II OT - gut dysbiosis ◼ hypertension OT - microglia OT - neuroinflammation ◼ paraventricular hypothalamic nucleus OT - tetracycline EDAT- 2019/01/08 06:00 MHDA- 2019/12/20 06:00 PMCR- 2020/03/01 CRDT- 2019/01/08 06:00 PHST- 2019/01/08 06:00 [pubmed] PHST- 2019/12/20 06:00 [medline] PHST- 2019/01/08 06:00 [entrez] PHST- 2020/03/01 00:00 [pmc-release] AID - 10.1161/CIRCRESAHA.118.313882 [doi] PST - ppublish SO - Circ Res. 2019 Mar;124(5):727-736. doi: 10.1161/CIRCRESAHA.118.313882.